Immune-mediated tumor control in the 5TGM1 transfer model of multiple myeloma
Z. Kellermayer, S. Tahri, M. M. E. De Jong, N. Papazian, C. Fokkema, R. Hoogenboezem, M. A. Sanders, L. Boon, C. Den Hollander, A. Broijl, P. Sonneveld, T. Cupedo
This study uses a murine model to show that C57Bl/6 mice can control multiple myeloma through IFN-gamma-dependent immune responses, highlighting the model's utility for studying anti-myeloma immunity.
bioRxiv · Jan 18, 2023 · PreprintImmunology